Foralumab stabilized disability for 6 months in all 10 people with nonactive SPMS who took part in an expanded access program, a study found.
A microglia replacement approach demonstrates that brain macrophages with patient mutations from Aicardi–Goutières syndrome, a genetic, brain predominant interferonopathy, are sufficient to drive ...
A Dartmouth study published in Nature Communications reveals that immune cells in the brain use a surprising two-step process ...
Brain-meningeal immunity is increasingly recognized as a central player in the complex network of interactions within the central nervous system (CNS).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results